Statements Of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$ (1,389,654)	$ 281,114
Adjustments to reconcile net (loss) income to net cash and cash equivalents used by operating activities:
Depreciation and amortization	28,549	17,042
Write off of deferred offering costs		10,163
Stock based compensation expense	752,450	83,168
Change in fair value of warrant liability		(1,499,852)
Increase (decrease) in allowance for doubtful accounts	8,698	(18,223)
Amortization of deferred loan costs		23,224
Amortization of discount on convertible note payable		358,555
(Increase) decrease in:
Accounts receivable	267,164	353,535
Other receivables		73,648
Inventory	38,430	67,043
Prepaid expenses and other assets	(7,181)	(84,238)
Increase (decrease) in:
Accounts payable and accrued expenses	(2,791)	338,701
Accrued compensation and related benefits	64,610	41,834
Deferred revenue	(100,839)	(257,459)
Net cash used by operating activities	(340,564)	(211,745)
CASH FLOWS FROM INVESTING ACTIVITIES:
Increase in patent costs	(33,493)	(4,905)
Purchase of property and equipment	(5,811)
Net cash used by investing activities	(39,304)	(4,905)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable, related party		50,000
Issuance of common stock	179,888
Net cash provided by financing activities	179,888	50,000
Net decrease in cash and cash equivalents	(199,980)	(166,650)
Cash and cash equivalents, beginning of period	294,150	262,740
Cash and cash equivalents, end of period	94,170	96,090
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest		343
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Revaluation of common stock issued for services		$ 105,000